Navigation Links
His Highness Sheikh Mohammed bin Zayed Al Nahyan and the Bill & Melinda Gates Foundation Partner to Immunize Children
Date:1/26/2011

n to the GAVI Alliance for the purchase and delivery of the pentavalent vaccine and for the introduction of the new pneumococcal vaccine in Afghanistan.   These vaccines help protect children from the biggest killers of children under five, including pneumonia, diphtheria, pertussis (whooping cough), tetanus, hepatitis B, and Haemophilus influenzae type B (HiB), which causes meningitis.

The remaining $34 million of the allocated funds will be directed to the World Health Organization and UNICEF to deliver polio vaccines in Afghanistan and Pakistan.  Although worldwide polio has been reduced by 99 percent during the past 20 years, Afghanistan and Pakistan are two of only four countries where polio transmission has never been stopped.  To date, there has been a cycle of re-infection of this crippling disease between the populations of the two countries.

The partnership will result in the immunization of approximately five million children in Afghanistan against six deadly diseases, and will help the World Health Organization and UNICEF workers reach approximately 35 million children in Afghanistan and Pakistan with oral polio vaccines.

For high-resolution still photography and information about the foundation's work, please visit: www.gatesfoundation.org/press-room/Pages/news-market.aspx.

Bill & Melinda Gates Foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington,
'/>"/>

SOURCE Bill & Melinda Gates Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. R&J Public Relations Named Agency of Record for Aerocrine, Inc.
2. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
3. Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
4. eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals
5. Frost & Sullivan Recognizes BeClose as a Technology Innovator for Aging Independently in North America
6. W. L. Gore & Associates Continues Its Tradition as One of Nations Best Workplaces
7. Reportlinker Adds Hospital Radiography & Fluoroscopy Census
8. Combination of Home Blood Pressure Monitoring & Doctor Visits Keeps the Numbers You Need to Know in Check
9. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
10. S&P Equity Research Issues Health Care Sector Predictions for 2011
11. Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... and dosing of patients in its ongoing Phase 2 ... cancer under the revised clinical protocol agreed to with ... form of Halozyme,s proprietary recombinant human hyaluronidase under development ... "Our diligent effort to rapidly re-initiate ...
(Date:7/22/2014)... , July 22, 2014  Neurotrope Bioscience, Inc., a ... world-wide, exclusive license agreement with the Icahn School of ... Mount Sinai ) to utilize its proprietary ... in the treatment of Niemann-Pick Type C Disease (NPC), ... with Alzheimer-like symptoms. The license also covers other diseases ...
(Date:7/22/2014)... BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: ... has appointed Charles J. (Chuck) Bramlage and ... the Board.  Mr. Bramlage is a ... sales and other commercial functions.  He is currently the ... stage company that was recently acquired by AstraZeneca and ...
Breaking Medicine Technology:Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7
... WOONSOCKET, R.I., Oct. 18, 2011 A recent ... up germs, they are not doing all they can to ... receiving an annual flu shot as recommended by the Centers ... http://photos.prnewswire.com/prnh/20100816/NE50800LOGO) The CDC recommends that anyone ages 6 ...
... With connectivity enabled by Unlimited Systems Interlink integration ... only helps cancer clinics easily meet many of the ... saves time and money by reducing duplicate data entry, ... claims payment and reduced denials. Clinics can ...
Cached Medicine Technology:CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 2CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 3CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 4Navigating Cancer and Unlimited Systems Partner to Provide Cancer Clinics With IT Interoperability to Attain HITECH Act Incentives 2
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Mona ... instructor certification on August 15th & 16th, 2014, at ... industry's only structured and nationally accredited Bollywood workout was ... Powered by the globally appealing Bollywood culture, Bombay Jam® ... safe, easy to follow and designed with authentic Bollywood ...
(Date:7/22/2014)... IN (PRWEB) July 22, 2014 United ... advisory organization, announces that Les McPhearson, an insurance veteran ... as CEO effective immediately and be based in the ... said, "I am delighted that Les chose to accept ... perfectly qualified to address the many challenges facing UBA ...
(Date:7/22/2014)... The American Society of Hematology (ASH) will honor Tomas ... Los Angeles with the 2014 E. Donnall Thomas Lecture ... discovery of the iron-regulatory hormone hepcidin and investigation of ... the Nobel Prize Laureate and past Society president E. ... that have represented a paradigm shift or significant discovery ...
(Date:7/22/2014)... to heart disease, Dr. Ross Feldman says women are often ... was a men,s-only disease, however, data has shown that post-menopausal ... disease and are less likely to be adequately diagnosed and ... in the British Journal of Clinical Pharmacology brings ... and helps to identify which women are more prone to ...
(Date:7/22/2014)... disorders may share certain pathogenic mechanisms with cancer, according ... researcher Linda Kusner, Ph.D. , published in ... shifting work shows that the very same inhibitors of ... in cells that produce autoimmune diseases. Henry Kaminski, ... the GW School of Medicine and Health Sciences (SMHS), ...
Breaking Medicine News(10 mins):Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:Gene variant identified as a heart disease risk factor for women 2Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2
... the United States via Haiti, probably arriving in just one ... new research. , After the virus, HIV-1, entered the ... results show that the strain of virus that spawned the ... is earlier than a lot of people had imagined," said ...
... born and die without leaving a trace in any ... which to base public health decisions, a University of ... in a paper published today (Oct. 29, 2007) in ... solutions exist to collect these vital statistics and must ...
... prevent or shorten the illness , MONDAY, Oct. 29 (HealthDay ... help prevent pneumonia in elderly nursing home residents, a new ... at 617 people 65 and older in 33 nursing homes ... normal blood zinc concentrations were about 50 percent less likely ...
... Launch National Campaign to Inspire and ... Educate that Prevention is Possible, BERKELEY, Calif., Oct. 29 ... their lifetime. Although 50 percent,of women think breast cancer is hereditary, ... the disease. LUNA, the makers of whole nutrition bars for ...
... produced responses in 40% of patients with Philadelphia, chromosome-positive chronic myeloid ... ... and availability in US means Novartis can offer physicians and ... EAST HANOVER, N.J., Oct. 29 Tasigna(R),(nilotinib) capsules have been approved in ...
... and Los Angeles provide foundation for new education ... and research efforts to fight IPF, ... is pleased to announce that two major fundraising events,hosted in Chicago ... help those suffering from idiopathic pulmonary fibrosis (IPF), a,rare and deadly ...
Cached Medicine News:Health News:HIV's path out of Africa: Haiti, the US then the world 2Health News:HIV's path out of Africa: Haiti, the US then the world 3Health News:Scandal of invisibility plagues countries with no civil registries 2Health News:Scandal of invisibility plagues countries with no civil registries 3Health News:Zinc Helps Elderly Ward Off Pneumonia 2Health News:LUNA Pure Prevention Survey Confirms Breast Cancer Misconceptions 2Health News:LUNA Pure Prevention Survey Confirms Breast Cancer Misconceptions 3Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 2Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 3Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 4Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 5Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 6Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 7Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 8Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 9Health News:Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies 10Health News:Coalition for Pulmonary Fibrosis Fundraising Events Raise $280,000 for IPF 2Health News:Coalition for Pulmonary Fibrosis Fundraising Events Raise $280,000 for IPF 3
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
A straightforward, versatile approach to arthroscopically assisted pin placement in either the ankle or wrist....
... SureStep Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Medicine Products: